https://peptide.exchange/move/wegovy-pill-sales-beat-forecastsPeptide Exchangeen2026-11-05T05:04:00.000ZWegovy pill sales beat forecasts as Novo widens its oral GLP 1 lead https://peptide.exchange/move/cagrisema-tirzepatide-low-dose-neuropathyPeptide Exchangeen2026-11-05T04:19:00.000ZCagriSema vs tirzepatide edge at low doses leads Novo Q3 update as neuropathy data emerge https://peptide.exchange/move/wegovy-pill-market-share-iqvia-scriptsPeptide Exchangeen2026-11-05T03:51:00.000ZWegovy pill market share claim hinges on scripts IQVIA cannot see https://peptide.exchange/move/glp-1-alcohol-survey-drinkers-cut-backPeptide Exchangeen2026-11-04T04:49:00.000ZGLP 1 alcohol survey finds about half of drinkers cut back on treatment